Drug Trial Radar · NCT07223593
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,205
Planned (sponsor's estimate)
Start
Oct 31, 2025
Primary completion
Jun 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effect and safety of orforglipron once daily in participants with Fontaine II peripheral arterial disease (PAD). Participation in the study will last about 58 weeks.
Conditions
- Peripheral Arterial Disease
Interventions
OrforglipronDrug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Maximum Walking DistanceTime frame: Baseline, Week 52
Locations
169 sites in 18 countries. Site status is shown where the registry gives one.
St. Vincent's Birmingham Hospital
Birmingham, Alabama · Recruiting
Mercy Gilbert Medical Center
Gilbert, Arizona · Recruiting
Emvera Health at Peak Heart & Vascular Surprise
Surprise, Arizona · Completed
Del Sol Research Management, LLC
Tucson, Arizona · Recruiting
Angel City Research Inc.
Los Angeles, California · Not yet recruiting
Valley Clinical Trials, LLC dba Flourish Research
Northridge, California · Recruiting
The Cardiovascular Center
Redding, California · Recruiting
InvivoCure
Van Nuys, California · Recruiting
Interventional Cardiology Medical Group
West Hills, California · Recruiting
Rocky Mountain Regional VA Medical Center
Aurora, Colorado · Not yet recruiting
Lakeview Institute of Clinical Research
Leesburg, Florida · Recruiting
Inpatient Research Clinic
Miami Lakes, Florida · Recruiting
Floridian Clinical Research, LLC
Miami Lakes, Florida · Recruiting
St Johns Center for Clinical Research
Saint Augustine, Florida · Recruiting
Guardian Research Organization, LLC
Winter Park, Florida · Not yet recruiting
ASHA Clinical Research - Munster, LLC
Hammond, Indiana · Recruiting
Indiana University Health Methodist Hospital
Indianapolis, Indiana · Recruiting
Cardiovascular Research of Northwest Indiana
Munster, Indiana · Not yet recruiting
Deaconess Clinic- Gateway
Newburgh, Indiana · Recruiting
Flourish Research - Bowie
Bowie, Maryland · Recruiting
Capitol Cardiology Associates - Lanham Office
Lanham, Maryland · Not yet recruiting
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan · Recruiting
Capital Area Research, LLC
Camp Hill, Pennsylvania · Recruiting
The Jackson Clinic
Jackson, Tennessee · Recruiting
East Coast Institute for Research - Jefferson City
Jefferson City, Tennessee · Recruiting
Biopharma Informatic, LLC
Houston, Texas · Recruiting
Research Physicians Network, LLC
Houston, Texas · Recruiting
Sherman Clinical Research
Sherman, Texas · Recruiting
NextStage Clinical Research - Waco
Waco, Texas · Recruiting
Alpine Research Organization
Clinton, Utah · Recruiting
Stroobants Cardiovascular Center
Lynchburg, Virginia · Recruiting
Clinical Research Partners, LLC
Richmond, Virginia · Recruiting
Gershon Pain Specialists
Virginia Beach, Virginia · Recruiting
ERA Health Research - CardioNow - Lynnwood
Lynnwood, Washington · Completed
Eastside Research Associates
Redmond, Washington · Recruiting
CIPREC
Buenos Aires, Argentina · Recruiting
CIPREC
Buenos Aires, Argentina · Recruiting
Sanatorio Finochietto
Buenos Aires, Argentina · Recruiting
CEMEDIC
Buenos Aires, Argentina · Recruiting
Instituto de Investigaciones Clínicas Córdoba
Córdoba, Argentina · Recruiting
Showing 40 of 169 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.